Md. Code Regs. 10.18.02.01

Current through Register Vol. 51, No. 25, December 13, 2024
Section 10.18.02.01 - Scope
A. This chapter establishes the requirements for:
(1) Physician reporting of a:
(a) Case of human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS); and
(b) Birth of an infant whose mother has tested positive for HIV;
(2) Institution reporting of a case of HIV or AIDS;
(3) Laboratory reporting of a test result for:
(a) HIV detection;
(b) HIV viral load;
(c) CD4+ cell count or percentage; or
(d) HIV genotype sequence; and
(4) Follow-up of:
(a) A physician's report of HIV or AIDS;
(b) A physician's report of an infant whose mother has tested positive for HIV;
(c) An institution's report of HIV or AIDS; and
(d) A laboratory's report of a test result for:
(i) HIV detection;
(ii) HIV viral load;
(iii) CD4+ cell count or percentage; or
(iv) HIV genotype sequence infection or CD4+ count.
B. Except as noted in §C of this regulation, this chapter applies to all instances of laboratory testing of specimens from a human body for:
(1) HIV detection;
(2) HIV viral load;
(3) CD4+ cell count or percentage; or
(4) HIV genotype sequence.
C. This chapter does not apply if the specimen from a human body is:
(1) Not tested for:
(a) HIV detection;
(b) HIV viral load;
(c) CD4+ cell count or percentage; or
(d) HIV genotype sequence;
(2) Tested for HIV detection solely for the purpose of determining the suitability of the source individual as a prospective donor of blood, semen, or tissue;
(3) Taken from a patient at a designated anonymous HIV test site solely for the purpose of performing an anonymous HIV test;
(4) Tested for HIV detection as part of research conducted by an institution within Maryland under the following conditions:
(a) All personal identifiers are removed from the specimen before testing;
(b) The specimen cannot be linked to the individual from whom the specimen was taken;
(c) The result cannot be linked to the individual from whom the specimen was taken; and
(d) The research protocol has been approved by an institutional review board;
(5) Tested for HIV detection as part of research conducted under a research protocol approved by an institutional review board of an institution located outside of Maryland;
(6) Taken from a patient known to reside outside of the United States; or
(7) Tested for HIV detection as part of a research project that has been approved under Regulation .02 of this chapter for an exemption.

Md. Code Regs. 10.18.02.01

Regulation .01 amended effective 47:10 Md. R. 515, eff. 5/18/2020